[Form 4] iRhythm Technologies, Inc Insider Trading Activity

Rhea-AI Filing Summary

iRhythm Technologies, Inc. (IRTC) – Form 4 filing (02 July 2025)

Executive Vice President, Chief Medical Officer and Chief Scientific Officer Minang Turakhia reported a single open-market transaction on 2 July 2025. He sold 1,420 common shares at an average price of $145.41 per share, generating proceeds of roughly $206 k. The filing states the sale was executed solely to satisfy tax-withholding obligations related to recently vested restricted stock units (RSUs).

Following the sale, Turakhia’s direct ownership stands at 41,393 common shares. No derivative transactions were reported, and there were no changes to option or RSU holdings disclosed in this filing.

The volume sold represents approximately 3.3% of the insider’s previously reported direct shareholdings and is relatively immaterial when viewed against both insider ownership and iRhythm’s public float. Because the purpose was tax withholding, the transaction is generally considered routine and does not necessarily indicate a change in the insider’s view of the company’s prospects.

Insights

Securities Analyst

TL;DR: Routine insider sale for tax withholding; negligible impact on investment thesis.

The 1,420-share sale (~$206 k) by EVP Turakhia is small relative to his 41 k-share stake and iRhythm’s 30 m+ outstanding shares. The stated purpose—covering taxes on RSU vesting—suggests a non-discretionary transaction. Historical patterns show insiders often liquidate 15–40% of vesting RSUs for taxes; this 3.3% reduction is at the lower end. No derivative exercises or options sales were reported, indicating no broader divestiture trend. Overall, I classify the filing as neutral: it provides transparency but carries minimal valuation signal.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Freeman Sean Clinton

(Last) (First) (Middle)

C/O IRHYTHM TECHNOLOGIES INC.

699 8TH STREET, #600

(Street)

SAN FRANCISCO CA 94103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
iRhythm Technologies, Inc. [ IRTC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Strategy & Corp Devt

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		A		6,761(1)	A	$0	6,761	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on July 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

	/s/ Marc Rosenbaum, attorney-in-fact	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many iRhythm (IRTC) shares did EVP Minang Turakhia sell?

He sold 1,420 common shares on 2 July 2025.

What price did the iRhythm insider receive for the shares?

The shares were sold at an average price of $145.41 per share.

Why were the shares sold according to the Form 4 filing?

The sale was to cover tax-withholding obligations arising from vested RSUs.

How many iRhythm shares does the insider now own?

Following the transaction, Turakhia holds 41,393 shares directly.

Does this Form 4 include any derivative security transactions?

No. No options or other derivatives were exercised, acquired, or disposed of.